NOT KNOWN FACTS ABOUT POTENT THC STRAINS

The FDA has even authorized a drug manufactured with cannabidiol for that goal (Epidiolex). But the company only endorses it for two rare varieties of childhood epilepsy referred to as Lennox-Gastaut syndrome and Dravet syndrome.In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they plan to reclassify cannabis being a Plan III drug.